University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Dorzolamide 2% single use eye drops (SDU)

Specialist ophthalmologist recommendation

Status: Amber Dovobet gel
Status: Amber Dovobet ointment
Status: Amber Doxepin hydrochloride cream

RICaD (in development)

Status: Amber Duloxetine capsule
Status: Amber Duloxetine capsules (Cymbalta)

Specialist initiation only

Status: Amber Dutasteride capsules

RICaD

Status: Amber Eluxadoline (Truberzi®)

To be used in line with NICE TA 471. Specialist initiation, and transfer prescribing to GP using RICaD (in development).

Status: Amber Enalapril tablets

For existing patients only

Status: Amber Entacapone tablets

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top